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22 Ligusticum chuanxiong extract-polylactic acid sustained-release microspheres 
23 (LCE-PLA) are fabricated in this study for enhancing both duration and 
24 hepatoprotective efficacy of the main bioactive ingredients. LCE-PLA in vitro release, 
25 cytotoxicity and in vivo hepatoprotective effect were discussed to evaluate its 
26 efficiency and functionality. Results demonstrated that the optimal drug-loading rate 
27 and encapsulation efficiency of tetramethylpyrazine (TMP, the main active 
28 ingredient) were 8.19%, 83.72%, respectively. The LCE-PLA in vitro release of TMP 
29 showed prolong 5-fold and in vitro cytotoxicity declined 25.00% compared with 
30 naked LCE. After 6 weeks of in vivo intervention in high fat diet mice, both liver 
31 aspartate aminotransferase and alanine aminotransferase levels were higher in 
32 LCE-PLA group than LCE group. The above results indicated that TMP had a higher 
33 bioavailability of hepatoprotection when encapsulation of LCE-PLA was applied. The 
34 current study has provided a promising novel way to enhance the efficacy of short 
35 half-life ingredients. 




40 Long-term intake of high fat food (HFD) increases the body weight and results in 
41 obesity, and in turn causes serious damage to the liver like fatty liver and cirrhosis 
42 even hepatocellular carcinoma (Qin, Zhao, Zhou, Zhang, Wen, Tang, et al., 2018). 
43 Dietary therapy has been recommended for treatment of liver disease, especially for 
44 the cirrhosis and nonalcoholic fatty liver disease (Mager, Iniguez, Gilmour, & Yap, 
45 2015). Natural herbal dietary supplements are the most popular pathway due to its 
46 complex mechanisms as multi-compound, multitarget and multi-pathway 
47 (Brodziak-Dopierala, Fischer, Szczelina, & Stojko, 2018; Wang, Li, Zhao, Liu, Liu, 
48 Yang, et al., 2013). Traditional hepatic-protecting herbal plants, such as Ligusticum 
49 chuanxiong, Salvia, Angelica, Panax notoginseng, Astragalus, etc., have been 
50 reported to reduce serum aminotransferase degeneration and necrosis of liver cells 
51 and show anti-fibrosis effect (Gao, 2013).
52 Ligustrazine, also known as tetramethylpyrazine (TMP), is the major alkaloid in 
53 Ligusticum chuanxiong. TMP, with a simple structure, is well studied because of its 
54 multiple significant biological functions, such as inhibiting apoptosis, dilating blood 
55 vessels, protecting vascular endothelial cells and immune regulation, eliminating 
56 oxygen free radical, improving cerebral ischemia, inhibiting platelet aggregation, and 
57 promoting angiogenesis, effectively attenuate liver injury etc. (Mo, Liu, Li, Xu, Wen, 
58 Xian, et al., 2017; Yu, Guo, Zhang, Liu, Zou, Fu, et al., 2016). TMP has been 
59 extensively used for developing health-promoting foods.
60 However, the shortcoming of fast metabolism, short half-life (1.62 h), and poor 
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61 oral availability limit TMP application in liver therapy (Li, Song, Zhu, Yin, Ji, Li, et 
62 al., 2014). Sustained-release microspheres have been reported to help prolong the 
63 acting time of medicament, improve patient compliance and reduce side effects (Wu, 
64 Hu, & Jin, 2016). In addition, the majority studies on the sustained-release 
65 microspheres are based on the in vitro experiments such as antioxidant and cytoactive, 
66 but rare evaluation on the in vivo function and cytotoxicity. In this study, Ligusticum 
67 chuanxiong extract (LCE) was used to make sustained-release microspheres to 
68 enhance its bioavailability and efficiency of hepatoprotective. 
69 Polylactic acid (PLA), as a biodegradable polymer with the characteristic of high 
70 elastic modulus, high mechanical strength, and feasible processability, has been 
71 widely used in the preparation of slow-controlled release microspheres, especially in 
72 the preparation of composite microspheres (Surwase, Munot, Idage, & Idage, 2017). 
73 Traditional emulsion solvent evaporation method has been widely used to encapsulate 
74 hydrophilic drugs in polymeric particles (Murphy & Lampe, 2018). LCE can be 
75 soluble in water, W/O/W (water-in-oil-in-water) multiple emulsion technique is a 
76 useful method for water-soluble drug encapsulation (Bodmeier, Wang, & 
77 Bhagwatwar, 1992).
78 In the present study, LCE was incorporated in W/O/W multiple emulsions with 
79 PLA as the carrier material, tween-80 and PVA as the co-emulsifier. The technologies 
80 for encapsulating LCE were optimized and the microspheres were characterized with 
81 the drug-loading rate (DL), encapsulation efficiency (EE), morphology and in vitro 
82 cytotoxicity. Swelling ratios of the microspheres at different pH was evaluated for 
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83 unveiling the mechanism of the in vitro release profiles. Furthermore, the 
84 hepatoprotective effects in mice were evaluated. The outcome will favor the 
85 application of Ligusticum chuanxiong on liver therapy.
86 2 Materials and methods
87 2.1 Materials
88 Ligusticum chuanxiong (origin: Sichuan, the production license: 20160084). 
89 TMP standard (purity99.98%) was purchased from Shanghai Yuan ye 
90 Biotechnology Co. Ltd. Polyvinyl alcohol 124 (PVA, 1.05×105 Da). Chemical pure 
91 Tween-80, analytical reagent dichloromethane (DCM), analytical reagent methanol, 
92 NaH2PO4·2H2O, Na2HPO4·7H2O and potassium bromide were purchased from 
93 Sinopharm Chemical Reagent Co., Ltd. Polylactic acid powder (4500 Da) was 
94 purchased from America Nature Works. The defoaming agent (WH-Z) was purchased 
95 from Changzhou Jiangdong auxiliaries Co., Ltd.; Total triacylglycerols (TG), 
96 Cholesterol (TC), Aspartate aminotransferase (AST) and Alanine aminotransferase 
97 (ALT) kits were purchased from Nanjing Jiancheng Biological Engineering Institute.
98 2.2 Preparation of Ligusticum chuanxiong extraction 
99 Using 95% ethanol to reflux extraction 100.00 g Ligusticum chuanxiong powders 
100 (1:8, w/v) for 2 times and then freezing dried the extraction liquid for further use. 
101 2.3 Preparation of LCE-PLA
102 Ligusticum chuanxiong extract-polylactic acid sustained-release microspheres 
103 (LCE-PLA) were prepared through the emulsion solvent evaporation technique 
104 (Petkar, Chavhan, Kunda, Saleem, Somavarapu, Taylor, et al., 2018). LCE was 
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105 dissolved in distilled water (10 mg/mL) at 40 °C to prepare the internal water phase 
106 (W1). The oil phase (O) was prepared by mixing PLA with DCM (PLA/DCM, w/v) 
107 and stirring for 30 min at 24 °C. The external aqueous phase (W2) was prepared by 
108 adding PVA and Tween-80 (co-emulsifier) and shearing with a homogenizer at 9000 
109 rpm for 2 minutes. 
110 Phase W1 was added dropwise into the organic phase (O) to make W1 /O primary 
111 emulsion. W1 /O/ W2 composite emulsion was herein obtained by adding phase W2 
112 into the primary emulsion. The composite emulsion was homogenized to prepare 
113 stable multiple emulsions. After that, the organic phase was vaporized at 40 °C to get 
114 solid microspheres. The produced microspheres were collected by centrifugation at 
115 6,000 rpm, washed thrice with distilled water, and lyophilized overnight (Surwase, 
116 Munot, Idage, & Idage, 2017).
117 2.4 Determination of drug-loading rate and entrapment efficiency
118 TMP in LCE were quantified by high performance liquid chromatography 
119 (HPLC) according to our previous method (Ge, Chen, Chen, Tian, Liang, & Chen, 
120 2018). In brief, Waters XBridge C18 reversed phase column (600 Bar, 250mm×4.6 
121 mm, 5 μm) was used for chromatographic analysis. The mobile phase is methanol: 
122 1% glacial acetic acid aqueous solution= 45:55; velocity of flow is 0.80 mL/min; 
123 detection wavelength: 310 nm. Content of TMP in LCE is 55.69 mg/g. 
124 The DL and EE of TMP in microsphere were determined by the above HPLC 
125 method after the following pretreatment steps. Firstly, ten mg of microspheres was 
126 suspended in 10 mL of methanol and subjected to ultrasonic treatment at 80 W for 10 
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127 min and centrifuged the mixture at 10000 rpm for 10 min. Secondly, taken 1 mL 
128 supernatant were diluted to 10 mL with methanol and filtered through 0.22 mm 
129 membrane before determination. The DL and EE were calculated by following 
130 equations (Duan, Zhang, Chu, Tong, Liu, & Zhai, 2016):
131        (1)
132 (2)
133 2.5 Optimization preparation of LCE-PLA 
134 PLA concentrations (20, 30, 40, 50 and 60 mg/mL), PVA contents (0.60%, 
135 0.80%, 1.00%, 1.20% and 1.40%), shearing times (2, 3, 4, 5 and 6 min) and shearing 
136 speeds (7000, 8000, 9000, 10000 and 11000 rpm) were set as the factors to investigate 
137 the DL and EE of TMP in composite microspheres. During the preparation, Tween-80 
138 and PVA was used as a co-emulsifier, the scale of W1 and W2 was 1:20. The 
139 evaporation rate of solvent was set at 300 rpm for 4 h. 
140 2.6 Fourier transform infrared spectroscopy analysis
141 Fourier transform infrared (FT-IR) spectra of pure PLA, LCE and LCE-PLA 
142 obtained on a WQF-510 spectrometer (Campardelli, Oleandro, & Reverchon, 2016). 
143 Each sample was prepared in KBr discs (1.00%, w/w), and the scans were conducted 
144 over the range from 4000-400 cm-1. For each spectrum, 64 scans with air as the 
145 background were obtained at a resolution of 4 cm-1. Spectra over the range of 
146 4000-400 cm-1 were baseline corrected automatically, normalized and deconvoluted.
147 2.7 Morphology and particle size of microspheres
148 The morphology of LCE-PLA was observed by scanning electron microscopy 
8
149 (SEM) (Petkar, et al., 2018). Samples were mounted onto the metal holder and gold 
150 coated in a vacuum chamber, then recorded images at 15 KV acceleration voltage by 
151 JSM-6380LV SEM (JSM-6380LV, JEOL, Tokyo, Japan). 
152 The mean particle size of the W/O/W microsphere was measured by a laser 
153 particle-size analyzer (Beckman, Brea, CA, USA). The dry microspheres were placed 
154 in deionized water and stirred at 3000 rpm and sonicated at 50 mV until the 
155 light-blocking ratio between 5%-13%. Each sample measure three times. Afterwards, 
156 analyses the particle size of the W/O/W microspheres by the software provided. The 
157 median of particle size (D50±SD) was reported as the particle size of microspheres 
158 (Bagheri-Khoulenjani, Etrati-Khosroshahi, & Mirzadeh, 2010).
159 2.8 In-vitro drug release and swelling ratio 
160 LCE-PLA in-vitro release behaviors were determined according to the method of 
161 Surwase, Munot, Idage and Idage (2017). Fifty mg of microspheres was suspended in 
162 different phosphate buffer solutions (pH 1.2, pH 6.8, pH 7.4) to make the 
163 microspheres solution, then put the solutions into 3 dialysis bags (MW, 14000 Da) 
164 (Lin, Huo, Qin, Zhao, & Tao, 2017). Afterwards, the dialysis bags were put into 28 
165 mL phosphate buffer (pH 1.2, pH 6.8, pH 7.4) and maintained at 37±1 °C with 100 
166 rpm agitating for 10 hours. Withdraw 3 mL aliquots every half an hour, and an equal 
167 volume was replaced with fresh phosphate buffer each time and then determined at 
168 279 nm. Finally, quantify the released of drugs, and demonstrated the cumulative 
169 release profile with time at different pH conditions. All measurements were 
170 performed in three replicates, and results expressed as mean value ± SD.
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171 Swelling capacity of LCE-PLA at different pH (pH 1.2, pH 6.8, pH 7.4) were 
172 measured based on the method of Khattab and Zaki (2017). Three portions of 
173 lyophilized microspheres (each portion of 100 mg) were placed in pre-weighed dense 
174 gauze bag and weighed (W0), then put the bags into different mediums. Taken out the 
175 bags every 0.5 h, filter paper was then used to absorb the water attached to the 
176 microsphere surfaces, then weighted to get the wet microspheres weight (Wt) until the 
177 mass of microspheres keeps constant. Each pH situation was performed in three 
178 replicates. The swelling ratio (SR) was calculated as following equation:
179 (3) 
180 2.9 Cytotoxicity assay
181 To ensure the safety of the LCE-PLA, the cytotoxicity was measured following 
182 the method by Chen et al. (Chen, Tian, Ge, Liu, & Xiao, 2017; Yoon & Liu, 2007). 
183 Density of 4×104/well HepG2 cells and 100 µL growth medium were plated into a 
184 96-well plat and incubated at 37 °C for 24 h. After removing the growth medium, the 
185 cells were treated with 100 µL fresh medium (WME supplemented with 2 mM 
186 L-glutamine and 10 mM Hepes) with different concentrations of TMP, LCE, and 
187 LCE-PLA as samples or only Dimethyl sulfoxide (DMSO) as control for another 24 h 
188 at 37 °C. After that, each well was added 50 µL methylene blue solution, which 
189 contained by 98.00% HBSS, 0.67% glutaraldehyde, 0.60% methylene blue, the plat 
190 was stored at 37 °C for 1 h. Using water to rinse the cells until the water was clear and 
191 then dried cells. The elution solution, consisting of 49.00% PBS, 50.00% ethanol and 
192 1.00% acetic acid, were used to elute the methylene blue stain for 1 h at room 
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193 temperature. Finally, the absorbance was read at 570 nm with blank subtraction by an 
194 MRX II Dynex plate reader (Dynex Technologies, Inc., Chantilly, VA). 
195 Concentrations of the LCE-PLA or LCE or pure TMP that decreased the absorbance 
196 by more than 10.00% were considered cytotoxic compared with the control group. In 
197 the present study, the contents of TMP in LCE and LCE-PLA were equal to the pure 
198 TMP group. 
199 TMP stock solutions which concentration below 0.5 mg/ml were directly 
200 prepared by fresh medium, the concentration exceeded 0.5 mg/ml were dissolved in 
201 fresh medium contain 1% DMSO.
202 2.10 Animals and experimental design
203 Forty male Kunming mice weighing 20.00 ± 2 g were purchased from the 
204 Beijing HFK Bioscience CO..LTD (SCXK 20140004). The mice were housed in 
205 Animal Center of Fuzhou General Hospital of Nanjing Military Command at a 
206 constant temperature of 25 °C and humidity range of 50-60% with a 12-h light/dark 
207 cycle. After acclimatization for one week, the mice were randomly divided into two 
208 groups. The first group (normal-fat diet, NFD) is the normal, healthy control group (8 
209 mice) and the second group (Group II) is the HFD group (32 mice). During the 
210 6-week experimental period, all mice in group II were fed with HFD (containing 
211 5.00% sucrose, 10.00% lard oil, 2.00% cholesterol, 0.50% bile salts, 0.20% propyl 
212 thiouracil, 5.00% whole yolk powder, 5.00% bentonite and 72.30% NFD). Both NFD 
213 and HFD were provided by Beijing Keao Xieli Feed Co. Ltd.
214 Mice in group II were further classified into four groups: group II-a (HFD), 
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215 group II-b (HFD+S, commercial Simvastatin treated group at a dose of 6.00 mg/kg 
216 B.w./Day), group II-c (HFD+LCE, Liguticum chuanxiong alcohol extract treated 
217 group at a dose of 136.50 mg/kg B.w./Day) and group II-d (HFD+DM, drug-loading 
218 microspheres treated group at a dose of 163.00 mg/kg B.w./Day). In the current study, 
219 the LCE feeding dose was calculated according to the daily consumption (10.00 
220 g/day) of Liguticum chuanxiong crude rhizome recommended by Chinese medicine, 
221 and the extraction yield of LCE is about 9.10%. The dose of TMP in microspheres 
222 (EE of TMP 83.72%) was equal to which in LCE. Simvastatin as a positive common 
223 drug for treat hyperlipidemia, its dose was according to the clinic recommended by 
224 the instructions (Guo, Pan, Li, Li, Liu, & Lv, 2018). 
225 At the end of the experiment, all mice were injected intraperitoneally with 40 
226 mg/kg pentobarbital sodium, then collected blood samples from the abdominal aorta 
227 and centrifuged at 3000 g for 10 min to separate serum and stored at -20 °C. After 
228 that, all mice were sacrificed by cervical dislocation and dissected. The livers were 
229 quickly removed and washed with physiological saline and blotted dry on filter paper, 
230 partial liver tissues were taken for hepatic histological analysis by Hematoxylin-Eosin 
231 Stain (HE) (Guo, Pan, Li, Li, Liu, & Lv, 2018). 
232 2.11 Statistical analysis
233 One-way analysis of variance (ANOVA) was performed with Tukey’s HSD test 
234 (p<0.05) using SPSS (17.0 version, IBM). All results were expressed as mean ± 
235 standard deviation. The significance level was set as p<0.05.
236 3 Results and discussion
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237 3.1 Preparation optimization of LCE-PLA 
238 Research had found that different preparation process could affect the 
239 encapsulation rate of active ingredients (Ebrahimi, Saffari, & Langrish, 2017; Qiu, 
240 Zheng, Fang, Wang, Min, Shen, et al., 2018). As indicated in Table S1, with the 
241 increased of PVA addition level (PVA/Water, w/v), both DL and EE of TMP reached 
242 the maximum value at 6.83% and 69.91%, respectively. When the addition of PVA 
243 was greater than 0.80%, results of DL and EE showed no significant difference 
244 (p>0.05). Therefore, the addition of PVA was selected by 0.80% (PVA/Water, w/v). 
245 When the concentration of PLA increased to 40 mg/mL, effect of PLA addition on the 
246 DL and EE showed no significant difference (p>0.05). To save energy, the 
247 concentration of PLA was selected 20 mg/mL. Effect of shearing time on the DL and 
248 EE were significant difference in Table S1 (p<0.05). During the first 4 minutes, both 
249 DL and EE increased with the increase of shearing time. Interestingly, after 4 minutes, 
250 with the prolonger of shearing time, results of the DL and EE showed no significant 
251 difference (p>0.05). Influences of shearing force on the DL and EE were significant 
252 differences (p<0.05) in Table S1. With the increase of shearing force, the emulsion 
253 sizes become smaller, and the contact area is increased, thus, the DL and EE are 
254 increased. When the shearing force more than 1000, there was no significant different 
255 (p>0.05), thus chosen the shearing fore at 10000 rpm. To sum up, the reasonable 
256 preparation process is the PLA concentration of 20 mg/mL (PLA/DCM, w/v), PVA 
257 0.80% (PVA/Water, w/v), and shearing force at 10000 rpm for 4 min.
258 3.2 FT-IR spectroscopy
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259 FT-IR spectroscopy was carried out to characterize the interaction mechanism of 
260 LCE loaded in PLA microspheres. As illustrated in Fig. 1, the characteristic peaks 
261 around 3524 cm-1 and 3251 cm-1 (hydrogen bonds from -OH), as well as 1421 cm-1 
262 (stretching vibration of C=O), 1665 cm-1 (stretching vibrations of -C=N) and 992 cm-1 
263 (C=C) in LCE, disappeared in the LCE-PLA microspheres attributing to the adequate 
264 encapsulation process (Zou, Fu, Chen, Austarheim, Inngjerdingen, Huang, et al., 
265 2017). The characteristic peaks at 1391 cm-1 (stretching vibration of -CH3), 1756 cm-1 
266 (stretching vibration of C=O) and 1095 cm-1 (C-O-C) in PLA (Garlotta, 2001; 
267 Yuniarto, Purwanto, Purwanto, Welt, Purwadaria, & Sunarti, 2016) were sharply 
268 attenuated in the LCE-PLA microspheres might due to the interaction with LCE. 
269 Interestingly, the typical band of PLA at 2369 cm-1 (stretching vibration of C=O) was 
270 also disappeared in the LCE-PLA microspheres resulting from the interaction with 
271 LCE, which confirmed the internalization of C=O in PLA during the formation of 
272 microspheres.
273 3.3 Surface morphology of microspheres 
274 Mlalila, Swai, Kalombo and Hilonga (2014) found that higher emulsifier 
275 concentrations would decrease the interfacial tension via facilitating particle 
276 disruption. When PVA concentrations increased, the surfactants may form tighter 
277 micelles around microspheres, and resulted in the small size (Xu, Zhong, Liu, Xu, & 
278 Gao, 2011). In Fig. 2 C, the particle sizes of microspheres were surely smaller than 
279 that of A. In the Table S1, with the concentration of PVA (PVA/water, v/v) increased, 
280 the particle size (D50) declined from 18.78 µm to 10.50 µm, those results were in 
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281 agreement with the result of Li et al. (2013). When the PVA concentration increased, 
282 the surfactants might closely to form tighter micelles around the microspheres, which 
283 result in a smaller particle size. However, with the concentration of PLA increased, 
284 the mean particle sizes of microspheres increased from 11.41 µm to 17.90 µm in 
285 Table1, which can also be found in Fig. 2 B.
286 The resultant product by high-shear shows a smaller particle size compared with 
287 the emulsion produced by the conventional agitation (Patrick & James, 1997). 
288 Different speed resulted in the different particle size of microspheres, with the 
289 increasing of shearing speed, the particle size became smaller in Fig. 2 D. When 
290 shearing time increased, microspheres sizes were also declined in Fig. 2 E. 
291 Bagheri-Khoulenjani, Etrati-Khosroshahi and Mirzadeh (2010) found that high speed 
292 could help to decline the size of microspheres. 
293 SEM imaging of empty microspheres and broken microspheres were also studied 
294 (Fig. S1 A, C). The broken microspheres were prepared by a high temperature and 
295 high-pressure reactor (HTLAB). LCE-PLA was basically round, but slightly 
296 deformed when compared with the empty microspheres, this might be the cause of 
297 LCE combined into microspheres added the weight of microspheres. The broken 
298 microspheres SEM photographs were used to imitate the state of the microspheres 
299 after fully swelled and ruptured in the body (Chu, Liu, & Chen, 2018). 
300 Both Tween-80 and PVA is commonly used as emulsifier in preparation 
301 microspheres. The research found that the co-emulsifier can help improving 
302 emulsifying performance (Zhang & Haque, 2015). In the present study, Tween-80 and 
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303 PVA is used as the co-emulsifier to help enhance the quality of microspheres. Due to 
304 its high viscosity in aqueous solution, strong adsorption around the surfaces of the 
305 emulsion droplets, PVA could help make a smooth-surface and spherical morphology 
306 of microspheres (Feng & Huang, 2001) like the microspheres in Fig. 2 and Fig. S1. 
307 3.4 Microspheres swelling and ratio in-vitro drug release 
308 As illustrated in Fig. 3 A, the SR of microspheres increased following by time 
309 under different medium. At 3 h, the SMax value is 11.82% (pH 1.2), 15.02% (pH 6.8), 
310 and 16.19% (pH 7.4), respectively. Microspheres can be swelled well during the weak 
311 acidic and weak basic conditions. When the medium pH at 1.2, the SR increased 
312 slower compared with the other two mediums. Reports had found that process of 
313 swelling was related to the ionization and the protonation balance of the carboxyl 
314 groups. TMP mainly absorbed in the small intestine, during those conditions, the 
315 -COOR of PLA can slowly react with the basic condition solution (Metters, Anseth, 
316 & Bowman, 2000). TMP can be released in the intestine condition absolutely and 
317 prolonged the half-life.
318 The accumulative releasing rate of TMP in LCE-PLA under different pH media 
319 (pH 1.2, pH 6.8, pH 7.4) were shown in Fig. 3 B, the release could be sustained at 
320 least 10 h. Comparing with the TMP half-life, the microspheres duration of efficacy 
321 prolonged nearly 5-fold. Generally, the hydrolytic mechanism was considered as the 
322 mechanism of degradation of aliphatic polyester microspheres (Pistner, Bendix, 
323 Mühling, & Reuther, 1993) With the penetration of water, the prepared W/O/W PLA 
324 microspheres were substantially bulk erosion, degraded, and followed with the slow 
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325 diffusion of encapsulated drug, those results were consistent with the reports by Ford 
326 Versypt et al. (Ford Versypt, Pack, & Braatz, 2013; Li, Wang, Yu, Bao, & Li, 
327 2013).The prepared microspheres were first swelling in each condition solution, 
328 during this process, because of the ionization and the protonation balance of the 
329 carboxyl groups, the carrier material PLA can be absolutely hydrolysis especially in 
330 the weak basic conditions and released the activity compounds (Metters, Anseth, & 
331 Bowman, 2000). The SR of microspheres was reached to the highest at 3 h in Fig. 3 A 
332 and result in a high-speed release in Fig. 3 B. After 2 h, the cumulative releasing rate 
333 was reached to 38.00% of the median of pH 1.2 while the rate was over 50.00% at pH 
334 6.8 and pH 7.4. At 6 h, there was no significant difference in the release rate of 
335 microspheres between pH 6.8 and pH 7.4 (p>0.05). Result suggested that during the 
336 environment of weak acid or a weak base, the microspheres could be dissolved as 
337 well, which also indicated that the W/O/W composite microspheres could prolong the 
338 time of drug action. Research has found that a single administration of drug-loaded 
339 polymer microsphere could help the release of drug in a long period by the way of 
340 continuous and controlled, therefore, the drug concentration could retain in the within 
341 target (Ma, Yuan, Kang, Su, Yuan, Pu, et al., 2008).
342 3.5 Result of cytotoxicity and hepatotoxicity
343 Cytotoxicity as a significant criterion has been widely used to determine the 
344 suitability of polymers in drug delivery (Petkar, et al., 2018). In this paper, there were 
345 no significant difference in percent cell viability of LCE-PLA compared to the LCE, 
346 pure TMP and control group when the drug concentration below 0.8 mg/mL in Fig. 4. 
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347 The cytotoxicity of pure TMP, LCE and LCE-PLA became evident at the 
348 concentration of 1.50 mg/mL, 0.80 mg/mL, and 1.00 mg/mL, respectively. 
349 Cytotoxicity of LCE was declined 25.00% compared with LCE. Coowanitwong, 
350 Arya, Kulvanich and Hochhaus (2008) found that Rifampin-PLA microsphere 
351 formulations were low cytotoxicity. 
352 To investigate the hepatotoxicity of treatment contents, the hepatic TG, hepatic 
353 TC AST, ALT and hepatic histopathology of liver and kidney in all groups were 
354 determined. As shown in Fig. 5 A, the HFD groups mice hepatocytes were markedly 
355 swollen and enlarged, and it was easy to find that the hepatic nuclei were compressed 
356 to side and there were many fat vacuoles in the cytoplasm. In contrast, simvastatin, 
357 LCE and microspheres treatment improved the cellularity of liver cells, and smaller 
358 lipid droplets were observed compared with HFD. The liver weight in HFD, HFD+S, 
359 HFD+LCE, HFD+DM groups was increased in Table 1 compared with NFD group. 
360 The values of the above group livers weight Δ a (%), Δ b 1 (%), Δ c 1 (%) and Δ d 1 
361 (%) in Table 1 was 31.34, 10.45, 24.88 and 11.44, respectively. Report had found that 
362 the increase of liver coefficient could indicate edema, inflammation, or hyperplasia in 
363 the liver tissue (Bezan, Mrsic, Krieger, Stojakovic, Pummer, Zigeuner, et al., 2015). 
364 Results indicated that LCE-PLA had a helpful effect on the liver injury mice induced 
365 by HFD. And the effect of above treatment activity compounds followed as: 
366 Simvastatin > LCE-PLA > LCE. Fig. 5 B showed the histological analysis of kidney 
367 sections. In the treatment group, the renal tubules were clear and the cells arranged 
368 regularly while the HFD group showed the opposite situation such as narrowing of the 
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369 renal tubule, cells fusion and glomerulonephritis. In Table 1, NFD group and 
370 treatment groups had the same kidney weight, those mice kidney were normal.
371 AST and ALT are well-known liver enzymes produced by both malignant and 
372 non-malignant cells and have been widely used in the evaluation of various causes of 
373 liver disease such as viral hepatitis and alcohol abuse etc. (Bezan, et al., 2015; Lee, 
374 Lee, Byun, Kim, Kwak, & Hong, 2017). In Fig. 5 C, the value of hepatic TG and TC 
375 in HFD group were higher than which in treatment groups, while the AST and ALT 
376 showed the opposite (p<0.01). When the liver injury, the AST and ALT will be 
377 released into the blood and reduced the content in liver tissue. In the current study, in 
378 each treatment group, levels of both AST and ALT were as follows: 
379 NFD>HFD+S>HFD+DM>HFD+LCE. The above results confirmed that the 
380 hepatotoxicity of treatment activity compounds was low and TMP in LCE-PLA could 
381 produce a better curative effect. 
382 4 Conclusions 
383 In the present study, LCE-PLA were synthesized and characterized. The 
384 proposed LCE-PLA EE was more than 80.00%, and the duration prolonged nearly 
385 5-fold compared with the naked LCE. In vitro cytotoxicity assay and in vivo 
386 hepatoprotective effect confirmed that LCE-PLA enhanced the solubility and 
387 bioavailability of active compounds, even declined the cytotoxicity of LCE. Overall, 
388 these findings indicated that release microspheres can be a useful way to improve the 
389 Ligusticum chuanxiong clinical use. Furthermore, this study can provide a promising 
390 novel way to enhance the efficacy of short half-life ingredients.
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568  Sustained-release microspheres encapsulation efficiency of TMP are more 
569 than 80% 
570  LCE-PLA microspheres duration of efficacy prolong nearly 5-fold
571  LCE-PLA microspheres cytotoxicity declined 25% than naked LCE
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586 Figure 1 FI-RT of Ligusticum chuanxiong extraction (LCE), polylactic acid (PLA) 
587 and Ligusticum chuanxiong extract-polylactic acid microspheres (LCE-PLA) 
588 Figure 2 SEM of Ligusticum chuanxiong extract-polylactic acid microspheres 
589 (LCE-PLA) under different preparation technology. PVA, polyvinyl alcohol; DCM, 
590 dichloromethane. A to E is the SEM of drug-loading microspheres. The samples were 
591 observed using SEM with voltage 15 kV and 10000 x magnification. A is the 
592 microspheres made on the situation of PLA 20 mg/mL (PLA/ DCM, m/v), PVA 
593 0.80% (PVA / water, m/v), and shearing for 4 min at 9000 r/min; B changes the PLA 
594 to 30 mg/mL (PLA/ DCM, m/v) based on A; C changes the PVA additive amount of 
595 1.00% (PVA / water, m/v) compare to A; D the shearing force is changed to 10000 
596 r/min; E changes the shear time to 6 min based on A. 
26
597 Figure 3 Swelling curves (A) and cumulative release (B) of Ligusticum chuanxiong 
598 polylactic acid microspheres under different pH media (Mean ±SD, n=3)
599 Figure 4 Effect of Ligusticum chuanxiong extraction (LCE), Ligusticum 
600 chuanxiong-polylactic acid (LCE-PLA) microspheres and pure tetramethylpyrazine 
601 (TMP) on cytotoxicity in HepG2 cells (Mean ±SD, n=3). In the present study, the 
602 contents of TMP were equal in both LCE and LCE-PLA microspheres.
603 Figure 5 Representative histological analysis of liver sections (A) and kidney sections 
604 (B) from mice fed on NFD (normal-fat diet), HFD (High fat diet), HFD+S (HFD + 
605 6.00 mg/kg B.w./Day Simvastatin), HFD+LCE (HFD +136.50 mg/kg B.w./Day 
606 Liguticum chuanxiong alcohol extract), HFD+DM (HFD +163.00 mg/kg B.w./Day 
607 drug-loading microspheres) and drug-loading microspheres for 6 weeks and hepatic 
608 total cholesterol (TC), triglyceride (TG), aspartate aminotransferase (ALT), alanine 
609 aminotransferase (AST) levels in each group (C). Values are means ± SD (n=8). 
610 #p<0.05; ##p<0.01 means statistically significant difference compared to the NFD 

























633 Table 1 Impact of NFD, HFD, Simvastatin, TMP and LCE supplementation on 
634 alteration of body and organ weights of KM mice (means ± SD, n=8)























































































































































635 Notes: NFD: normal-fat diet; HFD: High fat diet; HFD+S: High fat diet + 6 mg/kg B.w./Day 
636 simvastatin; HFD+LCE: High fat diet +136.5 mg/kg B.w./day Liguticum chuanxiong alcohol 
637 extract; HFD+DM: High fat diet +163 mg/kg B.w./day drug-loading microspheres. 
638 Δ a difference between NFD and HFD; 
639 Δb1 difference between NFD and HFD +S; 
640 Δb2 difference between HFD and HFD +S; 
641 Δc1 difference between NFD and HFD + LCE; 
642 Δc2 difference between HFD and HFD + LCE; 
643 Δd1 difference between NFD and HFD + DM; 
644 Δd2 difference between HFD and HFD + DM. 
645
